AI-generated summary
The authors report an observational cohort study of 132 head and neck cancer patients receiving radiotherapy or chemoradiotherapy who were given photobiomodulation therapy for oral mucositis, compared with a historical control group of 100 patients. The PBMT group had lower peak mucositis grades, shorter periods of severe mucositis, and less opioid use, which the authors say was associated with improved outcomes. As an observational study with a historical control, these associations do not establish cause and effect.
- Participants
- 132
- Who or what was studied
- Patients with head and neck squamous cell carcinoma undergoing curative or adjuvant radiotherapy or chemoradiotherapy at a charitable oncology center in India
- Limits stated in the abstract
- The comparison group was a historical control cohort rather than a concurrent randomized control group, so the design is observational and cannot establish causation.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Oral mucositis, Near-infrared, GRADE. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.